{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "11728844",
  "DateCompleted": {
    "Year": "2002",
    "Month": "02",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "12",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0920-9964",
      "JournalIssue": {
        "Volume": "53",
        "Issue": "1-2",
        "PubDate": {
          "Year": "2002",
          "Month": "Jan",
          "Day": "01"
        }
      },
      "Title": "Schizophrenia research",
      "ISOAbbreviation": "Schizophr Res"
    },
    "ArticleTitle": "Latent inhibition deficits in high-schizotypal normals: symptom-specific or anxiety-related?",
    "Pagination": {
      "StartPage": "109",
      "EndPage": "121",
      "MedlinePgn": "109-21"
    },
    "Abstract": {
      "AbstractText": [
        "Latent inhibition (LI) is the phenomenon in which subjects who have repeatedly experienced an irrelevant stimulus perform more poorly on a new learning task with that stimulus than with a novel stimulus, presumably because of a decline in stimulus-specific attention. The present article reviews the literature on LI deficits in high-schizotypal normal subjects and schizophrenic patients. Although LI-deficits have been thought to be specific to these groups, evidence is presented that the effects may be related to the anxiety components of high-schizotypality and related pathologies."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychology, Tel Aviv University, Ramat Aviv 69978, Israel. braunh1@freud.tau.ac.il"
          }
        ],
        "LastName": "Braunstein-Bercovitz",
        "ForeName": "H",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rammsayer",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gibbons",
        "ForeName": "H",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lubow",
        "ForeName": "R E",
        "Initials": "RE"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Schizophr Res",
    "NlmUniqueID": "8804207",
    "ISSNLinking": "0920-9964"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis",
        "genetics",
        "psychology"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Attention"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Genetic Predisposition to Disease"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Inhibition, Psychological"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neuropsychological Tests"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychiatric Status Rating Scales"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Reference Values"
    },
    {
      "QualifierName": [
        "diagnosis",
        "genetics"
      ],
      "DescriptorName": "Schizophrenia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Schizophrenic Psychology"
    },
    {
      "QualifierName": [
        "diagnosis",
        "genetics",
        "psychology"
      ],
      "DescriptorName": "Schizotypal Personality Disorder"
    }
  ],
  "NumberOfReferences": "160"
}